We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+5.7%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$243B
AUM Growth
+$27.2B
Cap. Flow
+$15.3B
Cap. Flow %
6.3%
Top 10 Hldgs %
14.51%
Holding
8,546
New
751
Increased
3,655
Reduced
3,102
Closed
634

Sector Composition

Rank Sector Weight
1 Financials 7.78%
2 Technology 7.19%
3 Healthcare 5.6%
4 Industrials 5.06%
5 Consumer Discretionary 4.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCC icon
7526
ProShares UltraShort Consumer Discretionary
SCC
$6.76M
$2K ﹤0.01%
10
-17
-63% -$3.54K
SEED icon
7527
Origin Agritech
SEED
$12.1M
$2K ﹤0.01%
264
-753
-74% -$9.44K
SGRP
7528
DELISTED
SPAR Group
SGRP
$2K ﹤0.01%
+1,855
New +$2.06K
SMMT icon
7529
Summit Therapeutics
SMMT
$10.4B
$2K ﹤0.01%
210
-2,907
-93% -$32.4K
SPCE icon
7530
Virgin Galactic
SPCE
$328M
$2K ﹤0.01%
+12
New +$2.42K
SSY
7531
DELISTED
SunLink Health Systems
SSY
$2K ﹤0.01%
1,200
-6,088
-84% -$9.4K
TNXP icon
7532
Tonix Pharmaceuticals
TNXP
$160M
0
TROO icon
7533
TROOPS Inc
TROO
$208M
$2K ﹤0.01%
2,010
-1,390
-41% -$1.57K
TRX icon
7534
TRX Gold Corp
TRX
$254M
$2K ﹤0.01%
5,800
-20,082
-78% -$5.62K
USAS
7535
Americas Gold and Silver
USAS
$1.29B
$2K ﹤0.01%
+246
New +$2.41K
UTSL icon
7536
Direxion Daily Utilities Bull 3X ETF
UTSL
$40M
$2K ﹤0.01%
83
-1,285
-94% -$39.4K
XT icon
7537
iShares Future Exponential Technologies ETF
XT
$3.82B
$2K ﹤0.01%
70
XTLB
7538
XTL Biopharmaceuticals
XTLB
$6.93M
$2K ﹤0.01%
176
-584
-77% -$5.6K
YHGJ icon
7539
Yunhong Green CTI Ltd
YHGJ
$7.54M
$2K ﹤0.01%
49
+28
+133% +$1.09K
ASTH icon
7540
Astrana Health
ASTH
$1.76B
$2K ﹤0.01%
+100
New +$2.01K
IRD
7541
Opus Genetics
IRD
$306M
$2K ﹤0.01%
+20
New +$2.03K
TGEN
7542
Tecogen Inc
TGEN
$99.3M
$2K ﹤0.01%
646
+1
+0.2% +$3
LSXMB
7543
DELISTED
Liberty Media Corporation Series B Liberty SiriusXM Common Stock
LSXMB
$2K ﹤0.01%
72
-252
-78% -$8.09K
EMFM
7544
DELISTED
Global X MSCI Next Emerging & Frontier ETF
EMFM
$2K ﹤0.01%
+100
New +$2.34K
AVGR
7545
DELISTED
Avinger, Inc. Common Stock
AVGR
0
GENE
7546
DELISTED
Genetic Technologies Ltd.
GENE
$2K ﹤0.01%
100
-483
-83% -$9.08K
ESEB
7547
DELISTED
Xtrackers J.P. Morgan ESG Emerging Markets Sovereign ETF
ESEB
$2K ﹤0.01%
65
-103
-61% -$2.6K
DMK
7548
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$2K ﹤0.01%
7
-23
-77% -$7.57K
AENZ
7549
DELISTED
Aenza S.A.A.
AENZ
$2K ﹤0.01%
+211
New +$2.39K
OFED
7550
DELISTED
Oconee Federal Financial Corp.
OFED
$2K ﹤0.01%
58
+16
+38% +$471

Similar funds

UBS Group's Q4 2017 Portfolio in Review

As of Q4 2017, UBS Group held 8,546 positions worth $243B, up 13% from $216B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

UBS Group deployed $15.3B of net new capital in Q4 2017, opening 751 new positions and adding to 3,655 existing holdings. Its largest new stake was Columbia Diversified Fixed Income Allocation ETF: 857,912 shares worth $17.1M.

By sector, the portfolio is most concentrated in Financials at 7.8% of assets, up from 7.2% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $4.22B trimmed.

  • UBS Group's largest Q4 2017 buy was Columbia Diversified Fixed Income Allocation ETF: 857,912 shares worth $17.1M.
  • UBS Group added most to Apple in Q4 2017, an estimated $602M increase.
  • UBS Group's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.22B.
  • UBS Group fully exited Level 3 Communications Inc in Q4 2017, selling an estimated $139M.
  • UBS Group's ten largest holdings make up 15% of its $243B portfolio in Q4 2017.
  • UBS Group opened 751 new positions and closed 634 in Q4 2017.
  • UBS Group's portfolio value rose 13% quarter-over-quarter to $243B.

Based on UBS Group's 13F filing for Q4 2017, filed 14 Feb 2018.